Symbol:
Casp8ap2
Name:
caspase 8 associated protein 2
RGD ID:
1305771
Description:
Predicted to enable several functions, including SUMO polymer binding activity; cysteine-type endopeptidase activator activity involved in apoptotic process; and transcription corepressor activity. Predicted to be involved in Fas signaling pathway; cellular response to mechanical stimulus; and extrinsic apoptotic signaling pathway via death domain receptors. Located in cytoplasm and nucleus. Orthologous to human CASP8AP2 (caspase 8 associated protein 2); PARTICIPATES IN aldosterone signaling pathway; INTERACTS WITH 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
CASP8-associated protein 2; LOC313128
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 51,809,366 - 51,848,633 (+) NCBI GRCr8 mRatBN7.2 5 47,014,501 - 47,052,276 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 47,014,667 - 47,052,275 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 49,156,788 - 49,194,344 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 50,755,948 - 50,793,505 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 50,701,113 - 50,738,716 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 47,853,699 - 47,891,147 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 47,853,818 - 47,891,668 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 52,451,775 - 52,489,186 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 48,920,175 - 48,958,139 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 48,928,473 - 49,096,830 (+) NCBI Celera 5 45,775,811 - 45,813,420 (+) NCBI Celera Cytogenetic Map 5 q21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Casp8ap2 Rat 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o and p'-DDT analog results in increased expression of CASP8AP2 mRNA CTD PMID:22937105 Casp8ap2 Rat 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o more ... CTD PMID:22937105 Casp8ap2 Rat 1,2-dimethylhydrazine decreases expression ISO Casp8ap2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CASP8AP2 mRNA CTD PMID:22206623 Casp8ap2 Rat 1-chloro-2,4-dinitrobenzene affects binding ISO CASP8AP2 (Homo sapiens) 6480464 Dinitrochlorobenzene binds to CASP8AP2 protein CTD PMID:32991956 Casp8ap2 Rat 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO Casp8ap2 (Mus musculus) 6480464 2 more ... CTD PMID:24680724 Casp8ap2 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 2 more ... CTD PMID:27589474 Casp8ap2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Casp8ap2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CASP8AP2 mRNA CTD PMID:18691609 Casp8ap2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CASP8AP2 mRNA CTD PMID:32109520 and PMID:33387578 Casp8ap2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Casp8ap2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CASP8AP2 mRNA CTD PMID:24680724 Casp8ap2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CASP8AP2 mRNA CTD PMID:19520675 and PMID:34747641 Casp8ap2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Casp8ap2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CASP8AP2 mRNA CTD PMID:19465110 Casp8ap2 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of CASP8AP2 mRNA CTD PMID:21346803 Casp8ap2 Rat 4,4'-sulfonyldiphenol increases expression ISO Casp8ap2 (Mus musculus) 6480464 bisphenol S results in increased expression of CASP8AP2 mRNA CTD PMID:33297965 Casp8ap2 Rat 8'-apo-beta,psi-caroten-8'-al increases expression ISO CASP8AP2 (Homo sapiens) 6480464 apocarotenal results in increased expression of CASP8AP2 mRNA CTD PMID:17034753 Casp8ap2 Rat aflatoxin B1 increases expression ISO Casp8ap2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of CASP8AP2 mRNA CTD PMID:19770486 Casp8ap2 Rat aflatoxin B1 increases methylation ISO CASP8AP2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of CASP8AP2 intron CTD PMID:30157460 Casp8ap2 Rat aflatoxin M1 decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of CASP8AP2 mRNA CTD PMID:30928695 Casp8ap2 Rat aristolochic acid A decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of CASP8AP2 mRNA CTD PMID:33212167 Casp8ap2 Rat arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CASP8AP2 mRNA CTD PMID:19730151 Casp8ap2 Rat arsenous acid multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein] and Arsenic Trioxide results in increased localization of and results in increased degradation of CASP8AP2 protein CTD PMID:23673342 Casp8ap2 Rat atrazine decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 Atrazine results in decreased expression of CASP8AP2 mRNA CTD PMID:22378314 Casp8ap2 Rat benzatropine multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of CASP8AP2 protein CTD PMID:34122009 Casp8ap2 Rat benzo[a]pyrene affects methylation ISO CASP8AP2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CASP8AP2 intron CTD PMID:30157460 Casp8ap2 Rat benzo[a]pyrene diol epoxide I affects expression ISO CASP8AP2 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 Casp8ap2 Rat bis(2-chloroethyl) sulfide increases expression ISO Casp8ap2 (Mus musculus) 6480464 Mustard Gas results in increased expression of CASP8AP2 mRNA CTD PMID:15674844 Casp8ap2 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Casp8ap2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of CASP8AP2 mRNA CTD PMID:33754040 Casp8ap2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CASP8AP2 mRNA CTD PMID:25181051 and PMID:32145629 Casp8ap2 Rat C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CASP8AP2 mRNA CTD PMID:19167457 Casp8ap2 Rat cadmium dichloride decreases expression ISO Casp8ap2 (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of CASP8AP2 mRNA CTD PMID:24982889 Casp8ap2 Rat caffeine decreases phosphorylation ISO CASP8AP2 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of CASP8AP2 protein CTD PMID:35688186 Casp8ap2 Rat cannabidiol decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of CASP8AP2 mRNA CTD PMID:33244087 Casp8ap2 Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of CASP8AP2 mRNA CTD PMID:23125180 Casp8ap2 Rat chromium(6+) multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CASP8AP2 mRNA CTD PMID:38479592 Casp8ap2 Rat cisplatin increases expression ISO CASP8AP2 (Homo sapiens) 6480464 Cisplatin results in increased expression of CASP8AP2 mRNA CTD PMID:27594783 Casp8ap2 Rat copper(II) sulfate decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CASP8AP2 mRNA CTD PMID:19549813 Casp8ap2 Rat coumarin decreases phosphorylation ISO CASP8AP2 (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of CASP8AP2 protein CTD PMID:35688186 Casp8ap2 Rat coumestrol multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA CTD PMID:19167446 Casp8ap2 Rat Cuprizon multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of CASP8AP2 protein CTD PMID:34122009 Casp8ap2 Rat daidzein multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 Casp8ap2 Rat daidzein 7-O-beta-D-glucoside multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 Casp8ap2 Rat DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8AP2 mRNA CTD PMID:24576310 Casp8ap2 Rat DDE increases expression ISO CASP8AP2 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8AP2 mRNA CTD PMID:38568856 Casp8ap2 Rat dexamethasone decreases expression ISO Casp8ap2 (Mus musculus) 6480464 Dexamethasone results in decreased expression of CASP8AP2 mRNA CTD PMID:21041162 Casp8ap2 Rat diarsenic trioxide multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein] and Arsenic Trioxide results in increased localization of and results in increased degradation of CASP8AP2 protein CTD PMID:23673342 Casp8ap2 Rat diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CASP8AP2 mRNA CTD PMID:19730151 Casp8ap2 Rat diazinon affects expression EXP 6480464 Diazinon affects the expression of CASP8AP2 mRNA CTD PMID:22546817 Casp8ap2 Rat dieldrin affects expression EXP 6480464 Dieldrin affects the expression of CASP8AP2 mRNA CTD PMID:22546817 Casp8ap2 Rat diethylstilbestrol affects expression ISO CASP8AP2 (Homo sapiens) 6480464 Diethylstilbestrol affects the expression of CASP8AP2 mRNA CTD PMID:36621641 Casp8ap2 Rat dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of CASP8AP2 mRNA CTD PMID:26476374 Casp8ap2 Rat dioxygen multiple interactions EXP 6480464 Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8AP2 mRNA] CTD PMID:26476374 Casp8ap2 Rat doxorubicin decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CASP8AP2 mRNA CTD PMID:29803840 Casp8ap2 Rat folic acid decreases expression ISO Casp8ap2 (Mus musculus) 6480464 Folic Acid results in decreased expression of CASP8AP2 mRNA CTD PMID:25629700 Casp8ap2 Rat formaldehyde decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of CASP8AP2 mRNA CTD PMID:20655997 Casp8ap2 Rat FR900359 affects phosphorylation ISO CASP8AP2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of CASP8AP2 protein CTD PMID:37730182 Casp8ap2 Rat furan increases expression EXP 6480464 furan results in increased expression of CASP8AP2 mRNA CTD PMID:22079235 Casp8ap2 Rat genistein increases expression ISO CASP8AP2 (Homo sapiens) 6480464 Genistein results in increased expression of CASP8AP2 mRNA CTD PMID:15256057 Casp8ap2 Rat genistein multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 Casp8ap2 Rat genistein 7-O-beta-D-glucoside multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 Casp8ap2 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CASP8AP2 mRNA CTD PMID:22061828 Casp8ap2 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CASP8AP2 mRNA CTD PMID:33387578 Casp8ap2 Rat glycitein multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 Casp8ap2 Rat glycitin multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 Casp8ap2 Rat hydrogen peroxide decreases expression ISO CASP8AP2 (Homo sapiens) 155663665 hydrogen peroxide decreases expression of CASP8AP2 protein in umbilical vein endothelial cells RGD Casp8ap2 Rat ketoconazole affects expression ISO CASP8AP2 (Homo sapiens) 6480464 Ketoconazole affects the expression of CASP8AP2 mRNA CTD PMID:36621641 Casp8ap2 Rat methotrexate increases response to substance ISO CASP8AP2 (Homo sapiens) 6480464 CASP8AP2 mRNA results in increased susceptibility to Methotrexate CTD PMID:22753658 Casp8ap2 Rat methyl methanesulfonate increases expression ISO CASP8AP2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of CASP8AP2 mRNA CTD PMID:23649840 Casp8ap2 Rat Mitotane increases expression EXP 6480464 Mitotane analog results in increased expression of CASP8AP2 mRNA and Mitotane results in increased expression of CASP8AP2 mRNA CTD PMID:23485034 Casp8ap2 Rat N-nitrosodiethylamine increases expression ISO Casp8ap2 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CASP8AP2 mRNA CTD PMID:17854601 Casp8ap2 Rat N-nitrosodiethylamine multiple interactions ISO Casp8ap2 (Mus musculus) 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CASP8AP2 mRNA] CTD PMID:17854601 Casp8ap2 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CASP8AP2 mRNA CTD PMID:25729387 Casp8ap2 Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of CASP8AP2 mRNA CTD PMID:25729387 Casp8ap2 Rat p-menthan-3-ol decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 Menthol results in decreased expression of CASP8AP2 mRNA CTD PMID:26760959 Casp8ap2 Rat paracetamol affects expression ISO Casp8ap2 (Mus musculus) 6480464 Acetaminophen affects the expression of CASP8AP2 mRNA CTD PMID:17562736 Casp8ap2 Rat paracetamol increases expression ISO CASP8AP2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of CASP8AP2 mRNA CTD PMID:22230336 Casp8ap2 Rat perfluorooctane-1-sulfonic acid decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of CASP8AP2 mRNA CTD PMID:27153767 Casp8ap2 Rat propylparaben increases expression ISO CASP8AP2 (Homo sapiens) 6480464 propylparaben results in increased expression of CASP8AP2 mRNA CTD PMID:24481588 Casp8ap2 Rat quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8AP2 mRNA] CTD PMID:26476374 Casp8ap2 Rat resveratrol multiple interactions ISO CASP8AP2 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA CTD PMID:19167446 Casp8ap2 Rat resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CASP8AP2 mRNA CTD PMID:25905778 Casp8ap2 Rat silicon dioxide decreases expression ISO Casp8ap2 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of CASP8AP2 mRNA CTD PMID:19073995 Casp8ap2 Rat sodium arsenite increases expression ISO CASP8AP2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CASP8AP2 mRNA CTD PMID:17879257 Casp8ap2 Rat sodium arsenite decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CASP8AP2 mRNA CTD PMID:38568856 Casp8ap2 Rat sodium arsenite decreases expression ISO Casp8ap2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CASP8AP2 mRNA CTD PMID:16014739 Casp8ap2 Rat sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of CASP8AP2 mRNA CTD PMID:22110744 Casp8ap2 Rat sodium fluoride increases expression ISO Casp8ap2 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of CASP8AP2 mRNA CTD PMID:27862939 Casp8ap2 Rat succimer multiple interactions ISO Casp8ap2 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASP8AP2 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP8AP2 mRNA CTD PMID:21641980 and PMID:26378955 Casp8ap2 Rat tetrachloromethane increases expression ISO Casp8ap2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CASP8AP2 mRNA CTD PMID:31919559 Casp8ap2 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CASP8AP2 mRNA CTD PMID:34492290 Casp8ap2 Rat titanium dioxide decreases methylation ISO Casp8ap2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of CASP8AP2 gene and titanium dioxide results in decreased methylation of CASP8AP2 promoter CTD PMID:35295148 Casp8ap2 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CASP8AP2 mRNA CTD PMID:25729387 Casp8ap2 Rat trimellitic anhydride increases expression ISO Casp8ap2 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CASP8AP2 mRNA CTD PMID:19042947 Casp8ap2 Rat triphenyl phosphate affects expression ISO CASP8AP2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of CASP8AP2 mRNA CTD PMID:37042841 Casp8ap2 Rat triptonide decreases expression ISO Casp8ap2 (Mus musculus) 6480464 triptonide results in decreased expression of CASP8AP2 mRNA CTD PMID:33045310 Casp8ap2 Rat tungsten decreases expression ISO Casp8ap2 (Mus musculus) 6480464 Tungsten results in decreased expression of CASP8AP2 mRNA CTD PMID:30912803 Casp8ap2 Rat usnic acid increases expression ISO CASP8AP2 (Homo sapiens) 6480464 usnic acid results in increased expression of CASP8AP2 mRNA CTD PMID:32508146 Casp8ap2 Rat valproic acid decreases expression ISO CASP8AP2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CASP8AP2 mRNA CTD PMID:28001369
1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane (EXP) 1,2-dimethylhydrazine (ISO) 1-chloro-2,4-dinitrobenzene (ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 4,4'-sulfonyldiphenol (ISO) 8'-apo-beta,psi-caroten-8'-al (ISO) aflatoxin B1 (ISO) aflatoxin M1 (ISO) aristolochic acid A (ISO) arsenous acid (EXP,ISO) atrazine (ISO) benzatropine (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bis(2-chloroethyl) sulfide (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP) C60 fullerene (EXP) cadmium dichloride (ISO) caffeine (ISO) cannabidiol (ISO) chloroprene (EXP) chromium(6+) (ISO) cisplatin (ISO) copper(II) sulfate (ISO) coumarin (ISO) coumestrol (ISO) Cuprizon (ISO) daidzein (ISO) daidzein 7-O-beta-D-glucoside (ISO) DDE (EXP,ISO) dexamethasone (ISO) diarsenic trioxide (EXP,ISO) diazinon (EXP) dieldrin (EXP) diethylstilbestrol (ISO) dioxygen (EXP) doxorubicin (ISO) folic acid (ISO) formaldehyde (ISO) FR900359 (ISO) furan (EXP) genistein (ISO) genistein 7-O-beta-D-glucoside (ISO) gentamycin (EXP) glycitein (ISO) glycitin (ISO) hydrogen peroxide (ISO) ketoconazole (ISO) methotrexate (ISO) methyl methanesulfonate (ISO) Mitotane (EXP) N-nitrosodiethylamine (ISO) oxaliplatin (EXP) p-menthan-3-ol (ISO) paracetamol (ISO) perfluorooctane-1-sulfonic acid (ISO) propylparaben (ISO) quercetin (EXP) resveratrol (EXP,ISO) silicon dioxide (ISO) sodium arsenite (ISO) sodium dichromate (EXP) sodium fluoride (ISO) succimer (ISO) tetrachloromethane (ISO) thioacetamide (EXP) titanium dioxide (ISO) topotecan (EXP) trimellitic anhydride (ISO) triphenyl phosphate (ISO) triptonide (ISO) tungsten (ISO) usnic acid (ISO) valproic acid (ISO)
Casp8ap2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 51,809,366 - 51,848,633 (+) NCBI GRCr8 mRatBN7.2 5 47,014,501 - 47,052,276 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 47,014,667 - 47,052,275 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 49,156,788 - 49,194,344 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 50,755,948 - 50,793,505 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 50,701,113 - 50,738,716 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 47,853,699 - 47,891,147 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 47,853,818 - 47,891,668 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 52,451,775 - 52,489,186 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 48,920,175 - 48,958,139 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 48,928,473 - 49,096,830 (+) NCBI Celera 5 45,775,811 - 45,813,420 (+) NCBI Celera Cytogenetic Map 5 q21 NCBI
CASP8AP2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 6 89,829,880 - 89,874,436 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 6 89,829,894 - 89,874,436 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 6 90,539,599 - 90,584,155 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 6 90,596,379 - 90,640,876 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 6 90,596,378 - 90,640,875 NCBI Celera 6 90,958,564 - 91,004,713 (+) NCBI Celera Cytogenetic Map 6 q15 NCBI HuRef 6 87,756,992 - 87,803,539 (+) NCBI HuRef CHM1_1 6 90,637,186 - 90,681,833 (+) NCBI CHM1_1 T2T-CHM13v2.0 6 91,029,094 - 91,086,157 (+) NCBI T2T-CHM13v2.0
Casp8ap2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 32,615,462 - 32,653,271 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 32,615,451 - 32,653,265 (+) Ensembl GRCm39 Ensembl GRCm38 4 32,615,470 - 32,653,271 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 32,615,451 - 32,653,265 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 32,702,448 - 32,740,240 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 32,944,126 - 32,981,873 (+) NCBI MGSCv36 mm8 Celera 4 32,362,733 - 32,400,576 (+) NCBI Celera Cytogenetic Map 4 A5 NCBI cM Map 4 14.27 NCBI
Casp8ap2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 NW_004955411 16,535,646 - 16,568,139 (-) NCBI ChiLan1.0 ChiLan1.0
CASP8AP2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 5 109,912,615 - 109,959,693 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 6 107,811,413 - 107,860,815 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 6 87,707,152 - 87,754,836 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 6 90,979,710 - 91,026,770 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 6 90,996,127 - 91,023,757 (+) Ensembl panpan1.1 panPan2
CASP8AP2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 12 49,040,069 - 49,077,418 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 12 49,039,411 - 49,077,688 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 12 48,847,072 - 48,884,174 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 12 49,849,389 - 49,886,726 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 12 49,849,439 - 49,884,151 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 12 49,164,550 - 49,201,631 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 12 49,065,265 - 49,102,374 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 12 49,257,627 - 49,294,727 (+) NCBI UU_Cfam_GSD_1.0
Casp8ap2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404946 84,022,998 - 84,049,994 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936510 2,420,920 - 2,447,986 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936510 2,420,924 - 2,447,634 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CASP8AP2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 57,835,145 - 57,862,473 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 57,834,251 - 57,864,837 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 64,689,689 - 64,811,590 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CASP8AP2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 13 14,586,857 - 14,632,384 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 13 14,586,929 - 14,632,362 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666040 190,973,325 - 191,019,815 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Casp8ap2 (Heterocephalus glaber - naked mole-rat)
.
Assembly: mRatBN7.2
Assembly: RGSC_v3.4
Assembly: Rnor_5.0
Assembly: Rnor_6.0
Predicted Target Of
Count of predictions: 62 Count of miRNA genes: 49 Interacting mature miRNAs: 50 Transcripts: ENSRNOT00000009228 Prediction methods: Miranda Result types: miRGate_prediction
2293666 Bmd38 Bone mineral density QTL 38 4.4 femur size trait (VT:1000369) femoral neck cortical cross-sectional area (CMO:0001702) 5 8948228 53948228 Rat 1578776 Stresp18 Stress response QTL 18 2.9 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 5 27955440 72955440 Rat 1298067 Scl15 Serum cholesterol level QTL 15 4.8 0.001 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 33215665 78215665 Rat 1549845 Scl44 Serum cholesterol level QTL 44 6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 40128307 148607290 Rat 70212 Niddm25 Non-insulin dependent diabetes mellitus QTL 25 3.54 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 5 1 131345958 Rat 1358353 Srcrtb2 Stress Responsive Cort Basal QTL 2 3.48 0.003 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 5 18873947 74251464 Rat 1300117 Hrtrt8 Heart rate QTL 8 3.49 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 5 3844018 47869213 Rat 634305 Mamtr1 Mammary tumor resistance QTL 1 0.0001 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 12789751 113558310 Rat 1331801 Rf33 Renal function QTL 33 4.149 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 5 43726656 129132602 Rat 1598807 Glom12 Glomerulus QTL 12 2.7 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 5 33215665 78215665 Rat 1302786 Kidm8 Kidney mass QTL 8 28.15 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 5 33215665 78215665 Rat 6903292 Stl28 Serum triglyceride level QTL 28 2.6 0.0073 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 5 28515489 73515489 Rat 61462 Niddm10 Non-insulin dependent diabetes mellitus QTL 10 3.9 0.001 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 5 5112159 47171491 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 46711509 161317411 Rat 1578767 Stresp17 Stress response QTL 17 4.3 0.01 blood aldosterone amount (VT:0005346) plasma aldosterone level (CMO:0000551) 5 27955440 72955440 Rat 1641922 Alcrsp8 Alcohol response QTL 8 alcohol metabolism trait (VT:0015089) blood ethanol level (CMO:0000535) 5 35189153 68564008 Rat 1641912 Alcrsp18 Alcohol response QTL 18 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 5 35189153 141643988 Rat 1576314 Eutr1 Estrogen induced uterine response QTL 1 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 2138965 166875058 Rat 6903306 Scl35 Serum cholesterol QTL 35 2.6 0.0073 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 28515489 73515489 Rat 1576317 Eutr2 Estrogen induced uterine response QTL 2 0.01 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 34730116 104251008 Rat 7394712 Emca13 Estrogen-induced mammary cancer QTL 13 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 9823266 99753708 Rat 1331773 Scl26 Serum cholesterol level QTL 26 3.065 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 43726656 86724018 Rat 1331771 Rf35 Renal function QTL 35 4.36965 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 5 729470 86724018 Rat 8662454 Vetf3 Vascular elastic tissue fragility QTL 3 27.4 artery integrity trait (VT:0010639) number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562) 5 2282226 69540447 Rat 2290448 Scl54 Serum cholesterol level QTL 54 2.93 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 31663789 131345958 Rat 1641903 Alcrsp3 Alcohol response QTL 3 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 5 12689285 57689285 Rat 1331756 Rf34 Renal function QTL 34 4.16275 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 5 1 90450412 Rat 8552954 Pigfal14 Plasma insulin-like growth factor 1 level QTL 14 9 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 21226744 66226744 Rat 2316959 Gluco59 Glucose level QTL 59 4.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 5 34944474 113558310 Rat 1600358 Mamtr5 Mammary tumor resistance QTL 5 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 18873947 63873947 Rat
RH131147
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 47,051,920 - 47,052,170 (+) MAPPER mRatBN7.2 Rnor_6.0 5 47,890,786 - 47,891,035 NCBI Rnor6.0 Rnor_5.0 5 52,488,825 - 52,489,074 UniSTS Rnor5.0 RGSC_v3.4 5 48,957,785 - 48,958,034 UniSTS RGSC3.4 Celera 5 45,813,066 - 45,813,315 UniSTS RH 3.4 Map 5 248.0 UniSTS Cytogenetic Map 5 q21 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000009228 ⟹ ENSRNOP00000009227
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 47,014,667 - 47,052,275 (+) Ensembl Rnor_6.0 Ensembl 5 47,853,818 - 47,891,127 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000079656 ⟹ ENSRNOP00000075576
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 5 47,853,878 - 47,891,668 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000101963 ⟹ ENSRNOP00000085206
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 47,014,667 - 47,051,671 (+) Ensembl
RefSeq Acc Id:
NM_001107921 ⟹ NP_001101391
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 51,811,025 - 51,848,632 (+) NCBI mRatBN7.2 5 47,014,667 - 47,052,275 (+) NCBI Rnor_6.0 5 47,853,818 - 47,891,140 (+) NCBI Rnor_5.0 5 52,451,775 - 52,489,186 (+) NCBI RGSC_v3.4 5 48,920,175 - 48,958,139 (+) RGD Celera 5 45,775,811 - 45,813,420 (+) RGD
Sequence:
CGCGGGGCTGCTGGGGAGAGGCAGCGGGGTGCCGCCTGGGATGGCTTGCGCCGTGGGCGAAGGGTTGTGCCTGGCTGGGCCTCAAGGAGCCAGCTGCTGTCCTCGGGGACCGCCCTTTGGAGAGTCTC GAGGGGCTCTGGGGCGAGCACACGGAGCATCGCCCGGTCTACACTGCGCCCCTCCCCTCCCCCACCCGTGTCTCCTAGGTCCCTACTTCCGAGCTTTTGATGGCACCTATGAAAAGGATATAGGACCA TGGCAGCAGATGATGACAATGGTGATGGAACGGGTTTGTTTGATGTCTGTCCTGCCTCTCCTCTTAAAAATAATGATGAAGGCTCATTGGACATATATGCTGGGTTGGACAGTACTGTTTCTGACAGT ACTGCTAGGTCCTGCGTGTCGTTCAGAAACTGTCTGGATTTGTATGAAGAGATCCTGACTGAAGAAGGAACTGCAAAGGAGGCAACATACAGTGACTTGCAGATAGAATATGGGAAATGTCAGCAGCA AATGAAAGATCTGATGAAAAGATTTAAGGAAATACAGACACAGAACTTGAACTTAAAAAATGAAAACCAGTCTCTTAAGAAGAATATCTCAGCACTTATCAAAACTGCCAGAGTGGAGATAAACCGTA AGGATGAAGAGATAAATCATCTTCACCAAAGATTGTCTGAGTTTCCACATTTTCGAAATAACCATAAAACTGCAAGAACAAAAGATTCACGATCCAAATCTCCCCATTTGGACAATTGTTCAAAGACT GATCATGGAGTTAAAAGTGATGTTCAGAAAGATATACATCCTAACACTTCACAACCAAACTTGGAAAAGGAAGGGAAATCACATTCTGAAGCACAGAATTCTTTGCACTTGTCTACGGGTATTGAGAA ACATTGTACAAACAATGTCTGGTCACGTTCTCCTTACCAGGTTAGTGAAGGTAACTCAAATGAAGATAATAGAAGAGGAAGGAATGGCGTCAGACATAGCCAAGGTAGCAGAGGAACTGACAGAACAC AGAAAGACTTGAATAGCAGCTGTAATGATGGCGAGCCAAGGGACAAAGAGGCTGCTTCCAGACTACACGGAAACCCTGAGAAACATGGAAGCAGTGAAGCAAGGGCTGAGAACAAAATTTCAGAGATT AAAAGTAGCACTGGTTTGGGAAATAAAAGCGAGCGCAGTGCCTCTTCTTGGGAAAAAGAAACTTCCAGAGAAAGGCCACATACTCGAGTGGAACCTCAAAATGACAAAAATCTAGAGAGACAAAATGA AAGATTACAAAATACACACAGAAAAGAGCTTCAGTCTCAGGACAAAGCAGAAAGAAAAGGTGATGTGAAGTTTAAACCAGCAGGAGAGGAGCAGGGGCATCGGGGAAGAGTGGACCGTGCATTACCTC CTCATTCCAAGAATGACATGAAATATTATGGCTTCAATAAGTATCATCCAGAAGAGAGAAGGGGAAGGGAAGATGGTAAACGAGACAGAGGCATGAGCAGTCATGGCTTTCAAGATAGAAGATGTTCA TCTTCTCTTTCAAGCAACAGAAATAGCAAATACCCACACTCCAAGGAAGTCAGTGTTGCACACCAGTGGGAAAATACACCTTTCAAAGCAGAAAGACATAGAACTGAGGACAGGAGGAAAAGAGAACG AGAAAACAAAGAAGAAAGTAGACATGTGAAAAGTGACAAAAAATCACCTCCAGAACACTTGCAAAGGACTCATAAAGACACTAAGAAAAGTACTGCTAATGGAAAGAGACAGACGGAGCAGAAACACG GTAAAGGTCCAGTCTCTACCAGCGAGCTTTCTAAAGGGACAGACAATAGAGAGTGTACAATGAAAGTGGAGAATGGGCCAAATGAAGCAAAGGGCAAGGACTTAAAGTTAAGCTTCATGGAGAAGCTG AACTTAACTCTTTCTCCTGCTAAAAAGCAGCCTGTTTGTCAAGATAACGAGCATCAAATAATTGGTGTTCCCAAGCCCAGTGGCGTGTGTGACTCACAGTCCTTGGAGAAGACTGAAACAGTGGCATG TCTTCCTTCTGTCAGTGAACAAGATAGAGAGGAACCCAAATCAGAGTTACCAGAGCCAAAGGAGGCTCTTTCAGCAACATCTCAACCCAGGACCAGCATTCCAGAAAATAAAGTGAAGGAAGAAAATA GATTGTTATTTAAATCTGTTGAGAATACTGTGCCTTGTGAACTGCTTGCTTGTGGCACGGAAATTTCCTTCCCAGCACCTGTAGAAATTGAGCAAGCAAGATGTTTGGTCCAATCAATGGAAGTGGAA GAGACATGTGCTGGTGCAAGGGCAGCTGCTTCTGTGGTGATGCGTGTATTACCAGAACATGCTTCTGAAGACTTCAGCCAAGAATTGGGCACCAAAAGACATGATGATATAAATTCGTGTGATATTTC TGAAGGTGGGAAAAAAAAGGTGGTTCTTTCACCAAAAGCAGCAGCAGCCAGTGAGAGCCATCTGGAGCCTGTGGTTGAAGAACCTAGCATTTCACCAGTAAACTGTTCGGGAGACAATAATCCTAAAC TTGAACCTTCTCTTGAAGAGAGACCTAAGGTTGAGAATAAATCTTCTCCTTTGGAGCCTTGTTTACCTAAAGAGATGTTTGTACCTTCACCACAGAAGACTGAGTTGATTGACCACAAAATAGATACT GGAGAATCAAACTCGGTATATCAAGATGATGATAACTCAGTTTTGAGTATTGACTTTAATAATTTGAGACCTATTCCAGAACCCATCAGCCCTCTGAATAGTCCAGTGAGACCGGTATCCAAAGTTCT TAGCATGGAGAGCTCATGTACAATTCCACTGTATGATAGCAGCCATAAAGATGAGTTTCCATCCAATTCAACTCTTTCTACCTTCAAGAGTCAGTCTGATCTAAATAAGGAAAATGAAAAACCAGTTC CCAAATTGGACAAATGTTCAGAAGCAGAATCCTGTAAGAATTTGTCTGTAGATGAATTAGAAGAAGGGGAAATTAGAAGTGATGATGAAGAATCTGTAGCACAAAAGCGTTTGGAAAAGAGTGCAAGA CCCAGAACTTCTACTGAAGTGCCGCCAGGTAAAATCAGCCCAGGAAGCAGGAGGAGCACTGTGCATGTGCATAAGGATAACGGGAGGACAGTTGTAAAACTCCCTCGGGACAGAATCACATGGAGCCA AAGATCAAATGAATCTAGACCCTCAAACACCGAAAGGAAAAGTAAAACAATGAGCATCTCCAGCTTGGAAAAAATACTTCCGCTTATTCTTGCACCCTCCTCCGTATGGGAAGTTATGCATATGTTAC GGTTGCTAGGAAAACATGTAAGGAAAAATTACATGAAATTCAAGATAAAATTTTCATTGACACAATTTCATAGAATTATTGAATCGGCAATTTTGAGTTTCACATCACTAATTAGATACCTTGATTTG TCTAAGATCTGTAAATCAGTAAGTACTTTACAGAAGAGTCTTTGTGACGTTATAGAATCTAACCTTAAACAAGTGAAGAAGAATGGCATAGTTGACCGTTTATTTGAACAACAACAAACAGATATGAA AAAAAAATTGTGGAAGTTTGTGGATGAACAACTTGATTATTTGTTTGAAAAACTTAAAAAAATCCTACTAAAGTTTTGTGATTCTGTAAAGCATGAAAATGACAGTAGTGAAGGAAAACTTGGAAAAA AATATAAAGAGAGAGCCCAACATTCAAATTGTCAGAAGAAGAAAATGGACAACAAAGAAATACGGAGAGAAAAAGTGCTAAAATCAGAAAATACTGTGAATTTTAAATCTTCACTGGGGTGTGAAAAA TTTGAAGAAAAACATCAAGACCAAAATAAAACCAATACTACTACAGTAAAGCATGATGTGAAAAGAACTTTTAGCACTTGCACTGATAATAATACAAAGAACTCTGAATGTAAAGAGCAGTTTCTGGG AATGAACTGCCCGAGTACCCCCAGGCCAGGAGAAACTGAAGGCAATGTGGAGGAGGGGACACCGGCGGCACAGCACGCCTGCGTTAAGTCAGAGCGGGGCTTTGAGATCCTCACCGAGCAGCAGGCGT CCAGCCTTACTTTTAACTTAGTGAGTGACGCACAGATGGGTGAGATATTTAAAAGTTTGCTACAAGGTTCTGATCTGTTGGACACAGGTGGCACTGAAAAAGCGGAGTGGGAATTAAAGACTCCAGAG AAACAGCTGCTAGAGAGCCTCAAGTGTGAGTCTGCACCAGCTTGTACAACAGAAGAGCTAGTTTCAGAGGCGGCTTCTCTCTGTCCAAAGGTGATCAGTGATGATAATTGGTCTTTATTATCATCTGA AAAGGGCCCATCTCTATCTTCAGGGCTTTCACTGCCAGTTCATCCTGATGTGTTAGATGAAAATTGTATGTTTGAAGTATCTTCTAACCTTGCTTTAAGTAAAGATAATGTATACAGCTCAGAAAAGA GTAAGCCCTGCATTTCTTCCATACTCTTAGAAGATCTTGCGGTCTCTTTAACAGTACCGTCACCTCTGAAGTCAGATGGCCATTTGAGTTTCTTAAAGCCTGAAGTTTTGTCAACTTCAACTCCTGAA GAAGTTATTAGTGCACATTTTAGTGAGGATGCTTTGCTTGAGGAAGAGGATGCATCTGAACAGGACATTCACTTAGCTCTAGAGTCTGATAACTCAAGCAGTAAGTCAAGCTGTTCCTCATGGACAAG CCGGTCTGTTGCTTCAGGCTTTCAGTACCACCCTAATCTTCCCATGCATGCTGTCATTATGGAAAAGTCCAATGATCATTTCATTGTGAAAATACGGCGTGCAACACCATCTACCTCCCCTGGCCTTA AACATGGTATGGTAGCTGAGGAGTCGTTGACACCTTTGCCTAGAACTGGAAAAGAAGCTGATGGGGCAGCAGAGAAAGAACCTACCCTGTTTCAGAGTACAGTTTTAAACCCTGTCCAAGACTTGGAA AATTCCGACAAAAGTATTGATAAGAGCAAACCAACTCATGAAGATCAGAACTCTATAGTACAAACACAGGTTCCAGATATATACGAATTTCTTAAAGATGCTTCAAATAAGGTGGTTCATTGTGATCA AGTGGTTGATGATTGCTTCAAGTTGCATCAAGTATGGGAACCAAAAGTTTCTGAGAGCCTTCAAGAATTGCCTTCAATGGAAAAAAATGCACACTCTGTTGATGATCATCTTCCTAATACACACATAG ATCTAACAAAAGATCCAGCTACTGAGACTAAAAGCTTGGAGCTAATGGATGTAACAGTTTTAGATATCGATCACTTGGAACATTCTAAACCCAACTTAGATCAAGATGCACAGATAACGTGTACTTCG TTACAGCATGATGCTGTAGATGCTTTTATTGATTTGACACATGATGTTTCAAATGAGAGTAAAAACGAAAGTAATGAACCTGTGTTAACTGTTGAAGGTGTGGGATGCCAGGTAATATGTATAGATGA CGATAACCACAAAGAAGGAAAAGTGGGGAAGGTAAACAGTTCCTTAGAATGTACTGTTGAGGAAACCTGTATTGACTTGACCTCAGAGTCTGCTGGCTCCTTTGAAGTAAAGAGACACACTTTAAAGT CAGAGCCTCCATCAAAGTCGGATTGTTTAGAGTTGCCTGAGACTCTGGGGAATGGTCACAAGAAGAGAAAGAACAGTCCTGCTGTGAGTCACTCTTCTCAGAAAAAGCAAAGAAAGGACATGGACTTA AGTAGTGAAAAGACCAAGAGACTTAGTCCTAATTCTGATAGAACTGGTGATGCTCACAGAAAGCATGGCAGCAAGAAGAGGGAACCTGCAGTAAGTGACACATCCTTGTCATCAGAGGTCAACCCAGA GGTGAAGGGCTCAACAGCACCACTTGCTACTTTTCCAGGAAGCCTTTCTGCAAAAAATGTTATCAAAAAGAAAGGAGAAATTATAGTTTCATGGACAAGAAATGACGACAGGGAAATTTTACTGGAAT GTCAGAAAAGAATGCCGTCCCTGAAAACATTTACCCACTTGGCTGTCAAACTGAATAAAAATCCAAATCAGGTTTCAGAGAGGTTCCAGCAACTGAAAAAGCTTTTTGAGAAGTCAAAATGCAGGTAG TAGTGGGTCCATCGCAGGATGCTAATGCTATGAGTTGCTGGATTTCATGGTGCCTCACTGATAATTCTTCTACAAAGAAGCTTCGATTCCTCGTGTTTTAAATGGGGAACTAGGTGGAGGTTTTGTCT CAGTTTTGGTGACTAGATGATCATCTACCTTTTTTTTACTTTCCTGGTCATTGTGCTTGGCTTATTCAGATCAACAGTCTGATTCACTTTCCTGTTATTGGTCAGAATATTTATTTTTAATCATTAAA AGTTGTTATCAAATGAAAGAATAAAAGCAACCTCAATGTAATACTGAAACCTTAGTTTTGATATTGGATGAAATAACTTCTTTAGATTTTAAAAAACAATTTTGTAGCATTTTAAATGTAATGACTAT TTAGTTCACCTTTCTATTCATTTTTGTTTTTATAATTGCCTCATTTTGGAAAATTGTGAAATAATTTAAATAGTATATTTGTATATATGTATAATTATTGTAATGTAAAATACTATGACTGTATGTGT CTTGAGTGTATGTATGCACATGAATGGCTTTGCTAGCCAAAGGGTTTTTTTATCTATATAAAATATTTTGTATAAACTTTCCTTTCAGTTAGTCATGTATAATAAAAACATGTAAAGTCCTTTTT
hide sequence
RefSeq Acc Id:
XM_006237973 ⟹ XP_006238035
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 51,810,923 - 51,848,633 (+) NCBI mRatBN7.2 5 47,014,501 - 47,052,276 (+) NCBI Rnor_6.0 5 47,853,699 - 47,891,147 (+) NCBI Rnor_5.0 5 52,451,775 - 52,489,186 (+) NCBI
Sequence:
CGGTCCCGCCCTGGCGTCCTTACTGCGGGCTGGGATTGGTGGAGACGGCCGAGCGCCTGGCGTCCGGACAGCGGCCGCTGTGCGGGGCTGGCCGGCCGGAATGTGAAGAAACCGAGGCTTAAGCCCTT GTGAGACAAAGTCTGGCTGTATTGAGAGAAAAGATGGCACCTATGAAAAGGATATAGGACCATGGCAGCAGATGATGACAATGGTGATGGAACGGGTTTGTTTGATGTCTGTCCTGCCTCTCCTCTTA AAAATAATGATGAAGGCTCATTGGACATATATGCTGGGTTGGACAGTACTGTTTCTGACAGTACTGCTAGGTCCTGCGTGTCGTTCAGAAACTGTCTGGATTTGTATGAAGAGATCCTGACTGAAGAA GGAACTGCAAAGGAGGCAACATACAGTGACTTGCAGATAGAATATGGGAAATGTCAGCAGCAAATGAAAGATCTGATGAAAAGATTTAAGGAAATACAGACACAGAACTTGAACTTAAAAAATGAAAA CCAGTCTCTTAAGAAGAATATCTCAGCACTTATCAAAACTGCCAGAGTGGAGATAAACCGTAAGGATGAAGAGATAAATCATCTTCACCAAAGATTGTCTGAGTTTCCACATTTTCGAAATAACCATA AAACTGCAAGAACAAAAGATTCACGATCCAAATCTCCCCATTTGGACAATTGTTCAAAGACTGATCATGGAGTTAAAAGTGATGTTCAGAAAGATATACATCCTAACACTTCACAACCAAACTTGGAA AAGGAAGGGAAATCACATTCTGAAGCACAGAATTCTTTGCACTTGTCTACGGGTATTGAGAAACATTGTACAAACAATGTCTGGTCACGTTCTCCTTACCAGGTTAGTGAAGGTAACTCAAATGAAGA TAATAGAAGAGGAAGGAATGGCGTCAGACATAGCCAAGGTAGCAGAGGAACTGACAGAACACAGAAAGACTTGAATAGCAGCTGTAATGATGGCGAGCCAAGGGACAAAGAGGCTGCTTCCAGACTAC ACGGAAACCCTGAGAAACATGGAAGCAGTGAAGCAAGGGCTGAGAACAAAATTTCAGAGATTAAAAGTAGCACTGGTTTGGGAAATAAAAGCGAGCGCAGTGCCTCTTCTTGGGAAAAAGAAACTTCC AGAGAAAGGCCACATACTCGAGTGGAACCTCAAAATGACAAAAATCTAGAGAGACAAAATGAAAGATTACAAAATACACACAGAAAAGAGCTTCAGTCTCAGGACAAAGCAGAAAGAAAAGGTGATGT GAAGTTTAAACCAGCAGGAGAGGAGCAGGGGCATCGGGGAAGAGTGGACCGTGCATTACCTCCTCATTCCAAGAATGACATGAAATATTATGGCTTCAATAAGTATCATCCAGAAGAGAGAAGGGGAA GGGAAGATGGTAAACGAGACAGAGGCATGAGCAGTCATGGCTTTCAAGATAGAAGATGTTCATCTTCTCTTTCAAGCAACAGAAATAGCAAATACCCACACTCCAAGGAAGTCAGTGTTGCACACCAG TGGGAAAATACACCTTTCAAAGCAGAAAGACATAGAACTGAGGACAGGAGGAAAAGAGAACGAGAAAACAAAGAAGAAAGTAGACATGTGAAAAGTGACAAAAAATCACCTCCAGAACACTTGCAAAG GACTCATAAAGACACTAAGAAAAGTACTGCTAATGGAAAGAGACAGACGGAGCAGAAACACGGTAAAGGTCCAGTCTCTACCAGCGAGCTTTCTAAAGGGACAGACAATAGAGAGTGTACAATGAAAG TGGAGAATGGGCCAAATGAAGCAAAGGGCAAGGACTTAAAGTTAAGCTTCATGGAGAAGCTGAACTTAACTCTTTCTCCTGCTAAAAAGCAGCCTGTTTGTCAAGATAACGAGCATCAAATAATTGGT GTTCCCAAGCCCAGTGGCGTGTGTGACTCACAGTCCTTGGAGAAGACTGAAACAGTGGCATGTCTTCCTTCTGTCAGTGAACAAGATAGAGAGGAACCCAAATCAGAGTTACCAGAGCCAAAGGAGGC TCTTTCAGCAACATCTCAACCCAGGACCAGCATTCCAGAAAATAAAGTGAAGGAAGAAAATAGATTGTTATTTAAATCTGTTGAGAATACTGTGCCTTGTGAACTGCTTGCTTGTGGCACGGAAATTT CCTTCCCAGCACCTGTAGAAATTGAGCAAGCAAGATGTTTGGTCCAATCAATGGAAGTGGAAGAGACATGTGCTGGTGCAAGGGCAGCTGCTTCTGTGGTGATGCGTGTATTACCAGAACATGCTTCT GAAGACTTCAGCCAAGAATTGGGCACCAAAAGACATGATGATATAAATTCGTGTGATATTTCTGAAGGTGGGAAAAAAAAGGTGGTTCTTTCACCAAAAGCAGCAGCAGCCAGTGAGAGCCATCTGGA GCCTGTGGTTGAAGAACCTAGCATTTCACCAGTAAACTGTTCGGGAGACAATAATCCTAAACTTGAACCTTCTCTTGAAGAGAGACCTAAGGTTGAGAATAAATCTTCTCCTTTGGAGCCTTGTTTAC CTAAAGAGATGTTTGTACCTTCACCACAGAAGACTGAGTTGATTGACCACAAAATAGATACTGGAGAATCAAACTCGGTATATCAAGATGATGATAACTCAGTTTTGAGTATTGACTTTAATAATTTG AGACCTATTCCAGAACCCATCAGCCCTCTGAATAGTCCAGTGAGACCGGTATCCAAAGTTCTTAGCATGGAGAGCTCATGTACAATTCCACTGTATGATAGCAGCCATAAAGATGAGTTTCCATCCAA TTCAACTCTTTCTACCTTCAAGAGTCAGTCTGATCTAAATAAGGAAAATGAAAAACCAGTTCCCAAATTGGACAAATGTTCAGAAGCAGAATCCTGTAAGAATTTGTCTGTAGATGAATTAGAAGAAG GGGAAATTAGAAGTGATGATGAAGAATCTGTAGCACAAAAGCGTTTGGAAAAGAGTGCAAGACCCAGAACTTCTACTGAAGTGCCGCCAGGTAAAATCAGCCCAGGAAGCAGGAGGAGCACTGTGCAT GTGCATAAGGATAACGGGAGGACAGTTGTAAAACTCCCTCGGGACAGAATCACATGGAGCCAAAGATCAAATGAATCTAGACCCTCAAACACCGAAAGGAAAAGTAAAACAATGAGCATCTCCAGCTT GGAAAAAATACTTCCGCTTATTCTTGCACCCTCCTCCGTATGGGAAGTTATGCATATGTTACGGTTGCTAGGAAAACATGTAAGGAAAAATTACATGAAATTCAAGATAAAATTTTCATTGACACAAT TTCATAGAATTATTGAATCGGCAATTTTGAGTTTCACATCACTAATTAGATACCTTGATTTGTCTAAGATCTGTAAATCAGTAAGTACTTTACAGAAGAGTCTTTGTGACGTTATAGAATCTAACCTT AAACAAGTGAAGAAGAATGGCATAGTTGACCGTTTATTTGAACAACAACAAACAGATATGAAAAAAAAATTGTGGAAGTTTGTGGATGAACAACTTGATTATTTGTTTGAAAAACTTAAAAAAATCCT ACTAAAGTTTTGTGATTCTGTAAAGCATGAAAATGACAGTAGTGAAGGAAAACTTGGAAAAAAATATAAAGAGAGAGCCCAACATTCAAATTGTCAGAAGAAGAAAATGGACAACAAAGAAATACGGA GAGAAAAAGTGCTAAAATCAGAAAATACTGTGAATTTTAAATCTTCACTGGGGTGTGAAAAATTTGAAGAAAAACATCAAGACCAAAATAAAACCAATACTACTACAGTAAAGCATGATGTGAAAAGA ACTTTTAGCACTTGCACTGATAATAATACAAAGAACTCTGAATGTAAAGAGCAGTTTCTGGGAATGAACTGCCCGAGTACCCCCAGGCCAGGAGAAACTGAAGGCAATGTGGAGGAGGGGACACCGGC GGCACAGCACGCCTGCGTTAAGTCAGAGCGGGGCTTTGAGATCCTCACCGAGCAGCAGGCGTCCAGCCTTACTTTTAACTTAGTGAGTGACGCACAGATGGGTGAGATATTTAAAAGTTTGCTACAAG GTTCTGATCTGTTGGACACAGGTGGCACTGAAAAAGCGGAGTGGGAATTAAAGACTCCAGAGAAACAGCTGCTAGAGAGCCTCAAGTGTGAGTCTGCACCAGCTTGTACAACAGAAGAGCTAGTTTCA GAGGCGGCTTCTCTCTGTCCAAAGGTGATCAGTGATGATAATTGGTCTTTATTATCATCTGAAAAGGGCCCATCTCTATCTTCAGGGCTTTCACTGCCAGTTCATCCTGATGTGTTAGATGAAAATTG TATGTTTGAAGTATCTTCTAACCTTGCTTTAAGTAAAGATAATGTATACAGCTCAGAAAAGAGTAAGCCCTGCATTTCTTCCATACTCTTAGAAGATCTTGCGGTCTCTTTAACAGTACCGTCACCTC TGAAGTCAGATGGCCATTTGAGTTTCTTAAAGCCTGAAGTTTTGTCAACTTCAACTCCTGAAGAAGTTATTAGTGCACATTTTAGTGAGGATGCTTTGCTTGAGGAAGAGGATGCATCTGAACAGGAC ATTCACTTAGCTCTAGAGTCTGATAACTCAAGCAGTAAGTCAAGCTGTTCCTCATGGACAAGCCGGTCTGTTGCTTCAGGCTTTCAGTACCACCCTAATCTTCCCATGCATGCTGTCATTATGGAAAA GTCCAATGATCATTTCATTGTGAAAATACGGCGTGCAACACCATCTACCTCCCCTGGCCTTAAACATGGTATGGTAGCTGAGGAGTCGTTGACACCTTTGCCTAGAACTGGAAAAGAAGCTGATGGGG CAGCAGAGAAAGAACCTACCCTGTTTCAGAGTACAGTTTTAAACCCTGTCCAAGACTTGGAAAATTCCGACAAAAGTATTGATAAGAGCAAACCAACTCATGAAGATCAGAACTCTATAGTACAAACA CAGGTTCCAGATATATACGAATTTCTTAAAGATGCTTCAAATAAGGTGGTTCATTGTGATCAAGTGGTTGATGATTGCTTCAAGTTGCATCAAGTATGGGAACCAAAAGTTTCTGAGAGCCTTCAAGA ATTGCCTTCAATGGAAAAAAATGCACACTCTGTTGATGATCATCTTCCTAATACACACATAGATCTAACAAAAGATCCAGCTACTGAGACTAAAAGCTTGGAGCTAATGGATGTAACAGTTTTAGATA TCGATCACTTGGAACATTCTAAACCCAACTTAGATCAAGATGCACAGATAACGTGTACTTCGTTACAGCATGATGCTGTAGATGCTTTTATTGATTTGACACATGATGTTTCAAATGAGAGTAAAAAC GAAAGTAATGAACCTGTGTTAACTGTTGAAGGTGTGGGATGCCAGGTAATATGTATAGATGACGATAACCACAAAGAAGGAAAAGTGGGGAAGGTAAACAGTTCCTTAGAATGTACTGTTGAGGAAAC CTGTATTGACTTGACCTCAGAGTCTGCTGGCTCCTTTGAAGTAAAGAGACACACTTTAAAGTCAGAGCCTCCATCAAAGTCGGATTGTTTAGAGTTGCCTGAGACTCTGGGGAATGGTCACAAGAAGA GAAAGAACAGTCCTGCTGTGAGTCACTCTTCTCAGAAAAAGCAAAGAAAGGACATGGACTTAAGTAGTGAAAAGACCAAGAGACTTAGTCCTAATTCTGATAGAACTGGTGATGCTCACAGAAAGCAT GGCAGCAAGAAGAGGGAACCTGCAGTAAGTGACACATCCTTGTCATCAGAGGTCAACCCAGAGGTGAAGGGCTCAACAGCACCACTTGCTACTTTTCCAGGAAGCCTTTCTGCAAAAAATGTTATCAA AAAGAAAGGAGAAATTATAGTTTCATGGACAAGAAATGACGACAGGGAAATTTTACTGGAATGTCAGAAAAGAATGCCGTCCCTGAAAACATTTACCCACTTGGCTGTCAAACTGAATAAAAATCCAA ATCAGGTTTCAGAGAGGTTCCAGCAACTGAAAAAGCTTTTTGAGAAGTCAAAATGCAGGTAGTAGTGGGTCCATCGCAGGATGCTAATGCTATGAGTTGCTGGATTTCATGGTGCCTCACTGATAATT CTTCTACAAAGAAGCTTCGATTCCTCGTGTTTTAAATGGGGAACTAGGTGGAGGTTTTGTCTCAGTTTTGGTGACTAGATGATCATCTACCTTTTTTTTACTTTCCTGGTCATTGTGCTTGGCTTATT CAGATCAACAGTCTGATTCACTTTCCTGTTATTGGTCAGAATATTTATTTTTAATCATTAAAAGTTGTTATCAAATGAAAGAATAAAAGCAACCTCAATGTAATACTGAAACCTTAGTTTTGATATTG GATGAAATAACTTCTTTAGATTTTAAAAAACAATTTTGTAGCATTTTAAATGTAATGACTATTTAGTTCACCTTTCTATTCATTTTTGTTTTTATAATTGCCTCATTTTGGAAAATTGTGAAATAATT TAAATAGTATATTTGTATATATGTATAATTATTGTAATGTAAAATACTATGACTGTATGTGTCTTGAGTGTATGTATGCACATGAATGGCTTTGCTAGCCAAAGGGTTTTTTTATCTATATAAAATAT TTTGTATAAACTTTCCTTTCAGTTAGTCATGTATAATAAAAACATGTAAAGTCCTTTTTATTTTTA
hide sequence
RefSeq Acc Id:
XM_006237974 ⟹ XP_006238036
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 51,810,995 - 51,848,633 (+) NCBI mRatBN7.2 5 47,014,653 - 47,052,276 (+) NCBI Rnor_6.0 5 47,853,804 - 47,891,147 (+) NCBI Rnor_5.0 5 52,451,775 - 52,489,186 (+) NCBI
Sequence:
TCCTGAGGGCCTGTCGCGGGGCTGCTGGGGAGAGGCAGCGGGGTGCCGCCTGGGATGGCTTGCGCCGTGGGCGAAGGGTTGTGCCTGGCTGGGCCTCAAGGAGCCAGCTGCTGTCCTCGGGGACCGCC CTTTGGAGAGTCTCGAGGGGCTCTGGGGCGAGCACACGGAGCATCGCCCGGTCTACACTGCGCCCCTCCCCTCCCCCACCCGTGTCTCCTAGGTCCCTACTTCCGAGCTTTTGAATGTGAAGAAACCG AGGCTTAAGCCCTTGTGAGACAAAGTCTGGCTGTATTGAGAGAAAAGATGGCACCTATGAAAAGGATATAGGACCATGGCAGCAGATGATGACAATGGTGATGGAACGGGTTTGTTTGATGTCTGTCC TGCCTCTCCTCTTAAAAATAATGATGAAGGCTCATTGGACATATATGCTGGGTTGGACAGTACTGTTTCTGACAGTACTGCTAGGTCCTGCGTGTCGTTCAGAAACTGTCTGGATTTGTATGAAGAGA TCCTGACTGAAGAAGGAACTGCAAAGGAGGCAACATACAGTGACTTGCAGATAGAATATGGGAAATGTCAGCAGCAAATGAAAGATCTGATGAAAAGATTTAAGGAAATACAGACACAGAACTTGAAC TTAAAAAATGAAAACCAGTCTCTTAAGAAGAATATCTCAGCACTTATCAAAACTGCCAGAGTGGAGATAAACCGTAAGGATGAAGAGATAAATCATCTTCACCAAAGATTGTCTGAGTTTCCACATTT TCGAAATAACCATAAAACTGCAAGAACAAAAGATTCACGATCCAAATCTCCCCATTTGGACAATTGTTCAAAGACTGATCATGGAGTTAAAAGTGATGTTCAGAAAGATATACATCCTAACACTTCAC AACCAAACTTGGAAAAGGAAGGGAAATCACATTCTGAAGCACAGAATTCTTTGCACTTGTCTACGGGTATTGAGAAACATTGTACAAACAATGTCTGGTCACGTTCTCCTTACCAGGTTAGTGAAGGT AACTCAAATGAAGATAATAGAAGAGGAAGGAATGGCGTCAGACATAGCCAAGGTAGCAGAGGAACTGACAGAACACAGAAAGACTTGAATAGCAGCTGTAATGATGGCGAGCCAAGGGACAAAGAGGC TGCTTCCAGACTACACGGAAACCCTGAGAAACATGGAAGCAGTGAAGCAAGGGCTGAGAACAAAATTTCAGAGATTAAAAGTAGCACTGGTTTGGGAAATAAAAGCGAGCGCAGTGCCTCTTCTTGGG AAAAAGAAACTTCCAGAGAAAGGCCACATACTCGAGTGGAACCTCAAAATGACAAAAATCTAGAGAGACAAAATGAAAGATTACAAAATACACACAGAAAAGAGCTTCAGTCTCAGGACAAAGCAGAA AGAAAAGGTGATGTGAAGTTTAAACCAGCAGGAGAGGAGCAGGGGCATCGGGGAAGAGTGGACCGTGCATTACCTCCTCATTCCAAGAATGACATGAAATATTATGGCTTCAATAAGTATCATCCAGA AGAGAGAAGGGGAAGGGAAGATGGTAAACGAGACAGAGGCATGAGCAGTCATGGCTTTCAAGATAGAAGATGTTCATCTTCTCTTTCAAGCAACAGAAATAGCAAATACCCACACTCCAAGGAAGTCA GTGTTGCACACCAGTGGGAAAATACACCTTTCAAAGCAGAAAGACATAGAACTGAGGACAGGAGGAAAAGAGAACGAGAAAACAAAGAAGAAAGTAGACATGTGAAAAGTGACAAAAAATCACCTCCA GAACACTTGCAAAGGACTCATAAAGACACTAAGAAAAGTACTGCTAATGGAAAGAGACAGACGGAGCAGAAACACGGTAAAGGTCCAGTCTCTACCAGCGAGCTTTCTAAAGGGACAGACAATAGAGA GTGTACAATGAAAGTGGAGAATGGGCCAAATGAAGCAAAGGGCAAGGACTTAAAGTTAAGCTTCATGGAGAAGCTGAACTTAACTCTTTCTCCTGCTAAAAAGCAGCCTGTTTGTCAAGATAACGAGC ATCAAATAATTGGTGTTCCCAAGCCCAGTGGCGTGTGTGACTCACAGTCCTTGGAGAAGACTGAAACAGTGGCATGTCTTCCTTCTGTCAGTGAACAAGATAGAGAGGAACCCAAATCAGAGTTACCA GAGCCAAAGGAGGCTCTTTCAGCAACATCTCAACCCAGGACCAGCATTCCAGAAAATAAAGTGAAGGAAGAAAATAGATTGTTATTTAAATCTGTTGAGAATACTGTGCCTTGTGAACTGCTTGCTTG TGGCACGGAAATTTCCTTCCCAGCACCTGTAGAAATTGAGCAAGCAAGATGTTTGGTCCAATCAATGGAAGTGGAAGAGACATGTGCTGGTGCAAGGGCAGCTGCTTCTGTGGTGATGCGTGTATTAC CAGAACATGCTTCTGAAGACTTCAGCCAAGAATTGGGCACCAAAAGACATGATGATATAAATTCGTGTGATATTTCTGAAGGTGGGAAAAAAAAGGTGGTTCTTTCACCAAAAGCAGCAGCAGCCAGT GAGAGCCATCTGGAGCCTGTGGTTGAAGAACCTAGCATTTCACCAGTAAACTGTTCGGGAGACAATAATCCTAAACTTGAACCTTCTCTTGAAGAGAGACCTAAGGTTGAGAATAAATCTTCTCCTTT GGAGCCTTGTTTACCTAAAGAGATGTTTGTACCTTCACCACAGAAGACTGAGTTGATTGACCACAAAATAGATACTGGAGAATCAAACTCGGTATATCAAGATGATGATAACTCAGTTTTGAGTATTG ACTTTAATAATTTGAGACCTATTCCAGAACCCATCAGCCCTCTGAATAGTCCAGTGAGACCGGTATCCAAAGTTCTTAGCATGGAGAGCTCATGTACAATTCCACTGTATGATAGCAGCCATAAAGAT GAGTTTCCATCCAATTCAACTCTTTCTACCTTCAAGAGTCAGTCTGATCTAAATAAGGAAAATGAAAAACCAGTTCCCAAATTGGACAAATGTTCAGAAGCAGAATCCTGTAAGAATTTGTCTGTAGA TGAATTAGAAGAAGGGGAAATTAGAAGTGATGATGAAGAATCTGTAGCACAAAAGCGTTTGGAAAAGAGTGCAAGACCCAGAACTTCTACTGAAGTGCCGCCAGGTAAAATCAGCCCAGGAAGCAGGA GGAGCACTGTGCATGTGCATAAGGATAACGGGAGGACAGTTGTAAAACTCCCTCGGGACAGAATCACATGGAGCCAAAGATCAAATGAATCTAGACCCTCAAACACCGAAAGGAAAAGTAAAACAATG AGCATCTCCAGCTTGGAAAAAATACTTCCGCTTATTCTTGCACCCTCCTCCGTATGGGAAGTTATGCATATGTTACGGTTGCTAGGAAAACATGTAAGGAAAAATTACATGAAATTCAAGATAAAATT TTCATTGACACAATTTCATAGAATTATTGAATCGGCAATTTTGAGTTTCACATCACTAATTAGATACCTTGATTTGTCTAAGATCTGTAAATCAGTAAGTACTTTACAGAAGAGTCTTTGTGACGTTA TAGAATCTAACCTTAAACAAGTGAAGAAGAATGGCATAGTTGACCGTTTATTTGAACAACAACAAACAGATATGAAAAAAAAATTGTGGAAGTTTGTGGATGAACAACTTGATTATTTGTTTGAAAAA CTTAAAAAAATCCTACTAAAGTTTTGTGATTCTGTAAAGCATGAAAATGACAGTAGTGAAGGAAAACTTGGAAAAAAATATAAAGAGAGAGCCCAACATTCAAATTGTCAGAAGAAGAAAATGGACAA CAAAGAAATACGGAGAGAAAAAGTGCTAAAATCAGAAAATACTGTGAATTTTAAATCTTCACTGGGGTGTGAAAAATTTGAAGAAAAACATCAAGACCAAAATAAAACCAATACTACTACAGTAAAGC ATGATGTGAAAAGAACTTTTAGCACTTGCACTGATAATAATACAAAGAACTCTGAATGTAAAGAGCAGTTTCTGGGAATGAACTGCCCGAGTACCCCCAGGCCAGGAGAAACTGAAGGCAATGTGGAG GAGGGGACACCGGCGGCACAGCACGCCTGCGTTAAGTCAGAGCGGGGCTTTGAGATCCTCACCGAGCAGCAGGCGTCCAGCCTTACTTTTAACTTAGTGAGTGACGCACAGATGGGTGAGATATTTAA AAGTTTGCTACAAGGTTCTGATCTGTTGGACACAGGTGGCACTGAAAAAGCGGAGTGGGAATTAAAGACTCCAGAGAAACAGCTGCTAGAGAGCCTCAAGTGTGAGTCTGCACCAGCTTGTACAACAG AAGAGCTAGTTTCAGAGGCGGCTTCTCTCTGTCCAAAGGTGATCAGTGATGATAATTGGTCTTTATTATCATCTGAAAAGGGCCCATCTCTATCTTCAGGGCTTTCACTGCCAGTTCATCCTGATGTG TTAGATGAAAATTGTATGTTTGAAGTATCTTCTAACCTTGCTTTAAGTAAAGATAATGTATACAGCTCAGAAAAGAGTAAGCCCTGCATTTCTTCCATACTCTTAGAAGATCTTGCGGTCTCTTTAAC AGTACCGTCACCTCTGAAGTCAGATGGCCATTTGAGTTTCTTAAAGCCTGAAGTTTTGTCAACTTCAACTCCTGAAGAAGTTATTAGTGCACATTTTAGTGAGGATGCTTTGCTTGAGGAAGAGGATG CATCTGAACAGGACATTCACTTAGCTCTAGAGTCTGATAACTCAAGCAGTAAGTCAAGCTGTTCCTCATGGACAAGCCGGTCTGTTGCTTCAGGCTTTCAGTACCACCCTAATCTTCCCATGCATGCT GTCATTATGGAAAAGTCCAATGATCATTTCATTGTGAAAATACGGCGTGCAACACCATCTACCTCCCCTGGCCTTAAACATGGTATGGTAGCTGAGGAGTCGTTGACACCTTTGCCTAGAACTGGAAA AGAAGCTGATGGGGCAGCAGAGAAAGAACCTACCCTGTTTCAGAGTACAGTTTTAAACCCTGTCCAAGACTTGGAAAATTCCGACAAAAGTATTGATAAGAGCAAACCAACTCATGAAGATCAGAACT CTATAGTACAAACACAGGTTCCAGATATATACGAATTTCTTAAAGATGCTTCAAATAAGGTGGTTCATTGTGATCAAGTGGTTGATGATTGCTTCAAGTTGCATCAAGTATGGGAACCAAAAGTTTCT GAGAGCCTTCAAGAATTGCCTTCAATGGAAAAAAATGCACACTCTGTTGATGATCATCTTCCTAATACACACATAGATCTAACAAAAGATCCAGCTACTGAGACTAAAAGCTTGGAGCTAATGGATGT AACAGTTTTAGATATCGATCACTTGGAACATTCTAAACCCAACTTAGATCAAGATGCACAGATAACGTGTACTTCGTTACAGCATGATGCTGTAGATGCTTTTATTGATTTGACACATGATGTTTCAA ATGAGAGTAAAAACGAAAGTAATGAACCTGTGTTAACTGTTGAAGGTGTGGGATGCCAGGTAATATGTATAGATGACGATAACCACAAAGAAGGAAAAGTGGGGAAGGTAAACAGTTCCTTAGAATGT ACTGTTGAGGAAACCTGTATTGACTTGACCTCAGAGTCTGCTGGCTCCTTTGAAGTAAAGAGACACACTTTAAAGTCAGAGCCTCCATCAAAGTCGGATTGTTTAGAGTTGCCTGAGACTCTGGGGAA TGGTCACAAGAAGAGAAAGAACAGTCCTGCTGTGAGTCACTCTTCTCAGAAAAAGCAAAGAAAGGACATGGACTTAAGTAGTGAAAAGACCAAGAGACTTAGTCCTAATTCTGATAGAACTGGTGATG CTCACAGAAAGCATGGCAGCAAGAAGAGGGAACCTGCAGTAAGTGACACATCCTTGTCATCAGAGGTCAACCCAGAGGTGAAGGGCTCAACAGCACCACTTGCTACTTTTCCAGGAAGCCTTTCTGCA AAAAATGTTATCAAAAAGAAAGGAGAAATTATAGTTTCATGGACAAGAAATGACGACAGGGAAATTTTACTGGAATGTCAGAAAAGAATGCCGTCCCTGAAAACATTTACCCACTTGGCTGTCAAACT GAATAAAAATCCAAATCAGGTTTCAGAGAGGTTCCAGCAACTGAAAAAGCTTTTTGAGAAGTCAAAATGCAGGTAGTAGTGGGTCCATCGCAGGATGCTAATGCTATGAGTTGCTGGATTTCATGGTG CCTCACTGATAATTCTTCTACAAAGAAGCTTCGATTCCTCGTGTTTTAAATGGGGAACTAGGTGGAGGTTTTGTCTCAGTTTTGGTGACTAGATGATCATCTACCTTTTTTTTACTTTCCTGGTCATT GTGCTTGGCTTATTCAGATCAACAGTCTGATTCACTTTCCTGTTATTGGTCAGAATATTTATTTTTAATCATTAAAAGTTGTTATCAAATGAAAGAATAAAAGCAACCTCAATGTAATACTGAAACCT TAGTTTTGATATTGGATGAAATAACTTCTTTAGATTTTAAAAAACAATTTTGTAGCATTTTAAATGTAATGACTATTTAGTTCACCTTTCTATTCATTTTTGTTTTTATAATTGCCTCATTTTGGAAA ATTGTGAAATAATTTAAATAGTATATTTGTATATATGTATAATTATTGTAATGTAAAATACTATGACTGTATGTGTCTTGAGTGTATGTATGCACATGAATGGCTTTGCTAGCCAAAGGGTTTTTTTA TCTATATAAAATATTTTGTATAAACTTTCCTTTCAGTTAGTCATGTATAATAAAAACATGTAAAGTCCTTTTTATTTTTA
hide sequence
RefSeq Acc Id:
XM_006237975 ⟹ XP_006238037
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 51,809,366 - 51,848,633 (+) NCBI mRatBN7.2 5 47,014,581 - 47,052,276 (+) NCBI Rnor_6.0 5 47,853,743 - 47,891,147 (+) NCBI Rnor_5.0 5 52,451,775 - 52,489,186 (+) NCBI
Sequence:
ACGGCCGAGCGCCTGGCGTCCGGACAGCGGCCGCTGTGCGGGGCTGGCCGGCCGGATGGCACCTATGAAAAGGATATAGGACCATGGCAGCAGATGATGACAATGGTGATGGAACGGGTTTGTTTGAT GTCTGTCCTGCCTCTCCTCTTAAAAATAATGATGAAGGCTCATTGGACATATATGCTGGGTTGGACAGTACTGTTTCTGACAGTACTGCTAGGTCCTGCGTGTCGTTCAGAAACTGTCTGGATTTGTA TGAAGAGATCCTGACTGAAGAAGGAACTGCAAAGGAGGCAACATACAGTGACTTGCAGATAGAATATGGGAAATGTCAGCAGCAAATGAAAGATCTGATGAAAAGATTTAAGGAAATACAGACACAGA ACTTGAACTTAAAAAATGAAAACCAGTCTCTTAAGAAGAATATCTCAGCACTTATCAAAACTGCCAGAGTGGAGATAAACCGTAAGGATGAAGAGATAAATCATCTTCACCAAAGATTGTCTGAGTTT CCACATTTTCGAAATAACCATAAAACTGCAAGAACAAAAGATTCACGATCCAAATCTCCCCATTTGGACAATTGTTCAAAGACTGATCATGGAGTTAAAAGTGATGTTCAGAAAGATATACATCCTAA CACTTCACAACCAAACTTGGAAAAGGAAGGGAAATCACATTCTGAAGCACAGAATTCTTTGCACTTGTCTACGGGTATTGAGAAACATTGTACAAACAATGTCTGGTCACGTTCTCCTTACCAGGTTA GTGAAGGTAACTCAAATGAAGATAATAGAAGAGGAAGGAATGGCGTCAGACATAGCCAAGGTAGCAGAGGAACTGACAGAACACAGAAAGACTTGAATAGCAGCTGTAATGATGGCGAGCCAAGGGAC AAAGAGGCTGCTTCCAGACTACACGGAAACCCTGAGAAACATGGAAGCAGTGAAGCAAGGGCTGAGAACAAAATTTCAGAGATTAAAAGTAGCACTGGTTTGGGAAATAAAAGCGAGCGCAGTGCCTC TTCTTGGGAAAAAGAAACTTCCAGAGAAAGGCCACATACTCGAGTGGAACCTCAAAATGACAAAAATCTAGAGAGACAAAATGAAAGATTACAAAATACACACAGAAAAGAGCTTCAGTCTCAGGACA AAGCAGAAAGAAAAGGTGATGTGAAGTTTAAACCAGCAGGAGAGGAGCAGGGGCATCGGGGAAGAGTGGACCGTGCATTACCTCCTCATTCCAAGAATGACATGAAATATTATGGCTTCAATAAGTAT CATCCAGAAGAGAGAAGGGGAAGGGAAGATGGTAAACGAGACAGAGGCATGAGCAGTCATGGCTTTCAAGATAGAAGATGTTCATCTTCTCTTTCAAGCAACAGAAATAGCAAATACCCACACTCCAA GGAAGTCAGTGTTGCACACCAGTGGGAAAATACACCTTTCAAAGCAGAAAGACATAGAACTGAGGACAGGAGGAAAAGAGAACGAGAAAACAAAGAAGAAAGTAGACATGTGAAAAGTGACAAAAAAT CACCTCCAGAACACTTGCAAAGGACTCATAAAGACACTAAGAAAAGTACTGCTAATGGAAAGAGACAGACGGAGCAGAAACACGGTAAAGGTCCAGTCTCTACCAGCGAGCTTTCTAAAGGGACAGAC AATAGAGAGTGTACAATGAAAGTGGAGAATGGGCCAAATGAAGCAAAGGGCAAGGACTTAAAGTTAAGCTTCATGGAGAAGCTGAACTTAACTCTTTCTCCTGCTAAAAAGCAGCCTGTTTGTCAAGA TAACGAGCATCAAATAATTGGTGTTCCCAAGCCCAGTGGCGTGTGTGACTCACAGTCCTTGGAGAAGACTGAAACAGTGGCATGTCTTCCTTCTGTCAGTGAACAAGATAGAGAGGAACCCAAATCAG AGTTACCAGAGCCAAAGGAGGCTCTTTCAGCAACATCTCAACCCAGGACCAGCATTCCAGAAAATAAAGTGAAGGAAGAAAATAGATTGTTATTTAAATCTGTTGAGAATACTGTGCCTTGTGAACTG CTTGCTTGTGGCACGGAAATTTCCTTCCCAGCACCTGTAGAAATTGAGCAAGCAAGATGTTTGGTCCAATCAATGGAAGTGGAAGAGACATGTGCTGGTGCAAGGGCAGCTGCTTCTGTGGTGATGCG TGTATTACCAGAACATGCTTCTGAAGACTTCAGCCAAGAATTGGGCACCAAAAGACATGATGATATAAATTCGTGTGATATTTCTGAAGGTGGGAAAAAAAAGGTGGTTCTTTCACCAAAAGCAGCAG CAGCCAGTGAGAGCCATCTGGAGCCTGTGGTTGAAGAACCTAGCATTTCACCAGTAAACTGTTCGGGAGACAATAATCCTAAACTTGAACCTTCTCTTGAAGAGAGACCTAAGGTTGAGAATAAATCT TCTCCTTTGGAGCCTTGTTTACCTAAAGAGATGTTTGTACCTTCACCACAGAAGACTGAGTTGATTGACCACAAAATAGATACTGGAGAATCAAACTCGGTATATCAAGATGATGATAACTCAGTTTT GAGTATTGACTTTAATAATTTGAGACCTATTCCAGAACCCATCAGCCCTCTGAATAGTCCAGTGAGACCGGTATCCAAAGTTCTTAGCATGGAGAGCTCATGTACAATTCCACTGTATGATAGCAGCC ATAAAGATGAGTTTCCATCCAATTCAACTCTTTCTACCTTCAAGAGTCAGTCTGATCTAAATAAGGAAAATGAAAAACCAGTTCCCAAATTGGACAAATGTTCAGAAGCAGAATCCTGTAAGAATTTG TCTGTAGATGAATTAGAAGAAGGGGAAATTAGAAGTGATGATGAAGAATCTGTAGCACAAAAGCGTTTGGAAAAGAGTGCAAGACCCAGAACTTCTACTGAAGTGCCGCCAGGTAAAATCAGCCCAGG AAGCAGGAGGAGCACTGTGCATGTGCATAAGGATAACGGGAGGACAGTTGTAAAACTCCCTCGGGACAGAATCACATGGAGCCAAAGATCAAATGAATCTAGACCCTCAAACACCGAAAGGAAAAGTA AAACAATGAGCATCTCCAGCTTGGAAAAAATACTTCCGCTTATTCTTGCACCCTCCTCCGTATGGGAAGTTATGCATATGTTACGGTTGCTAGGAAAACATGTAAGGAAAAATTACATGAAATTCAAG ATAAAATTTTCATTGACACAATTTCATAGAATTATTGAATCGGCAATTTTGAGTTTCACATCACTAATTAGATACCTTGATTTGTCTAAGATCTGTAAATCAGTAAGTACTTTACAGAAGAGTCTTTG TGACGTTATAGAATCTAACCTTAAACAAGTGAAGAAGAATGGCATAGTTGACCGTTTATTTGAACAACAACAAACAGATATGAAAAAAAAATTGTGGAAGTTTGTGGATGAACAACTTGATTATTTGT TTGAAAAACTTAAAAAAATCCTACTAAAGTTTTGTGATTCTGTAAAGCATGAAAATGACAGTAGTGAAGGAAAACTTGGAAAAAAATATAAAGAGAGAGCCCAACATTCAAATTGTCAGAAGAAGAAA ATGGACAACAAAGAAATACGGAGAGAAAAAGTGCTAAAATCAGAAAATACTGTGAATTTTAAATCTTCACTGGGGTGTGAAAAATTTGAAGAAAAACATCAAGACCAAAATAAAACCAATACTACTAC AGTAAAGCATGATGTGAAAAGAACTTTTAGCACTTGCACTGATAATAATACAAAGAACTCTGAATGTAAAGAGCAGTTTCTGGGAATGAACTGCCCGAGTACCCCCAGGCCAGGAGAAACTGAAGGCA ATGTGGAGGAGGGGACACCGGCGGCACAGCACGCCTGCGTTAAGTCAGAGCGGGGCTTTGAGATCCTCACCGAGCAGCAGGCGTCCAGCCTTACTTTTAACTTAGTGAGTGACGCACAGATGGGTGAG ATATTTAAAAGTTTGCTACAAGGTTCTGATCTGTTGGACACAGGTGGCACTGAAAAAGCGGAGTGGGAATTAAAGACTCCAGAGAAACAGCTGCTAGAGAGCCTCAAGTGTGAGTCTGCACCAGCTTG TACAACAGAAGAGCTAGTTTCAGAGGCGGCTTCTCTCTGTCCAAAGGTGATCAGTGATGATAATTGGTCTTTATTATCATCTGAAAAGGGCCCATCTCTATCTTCAGGGCTTTCACTGCCAGTTCATC CTGATGTGTTAGATGAAAATTGTATGTTTGAAGTATCTTCTAACCTTGCTTTAAGTAAAGATAATGTATACAGCTCAGAAAAGAGTAAGCCCTGCATTTCTTCCATACTCTTAGAAGATCTTGCGGTC TCTTTAACAGTACCGTCACCTCTGAAGTCAGATGGCCATTTGAGTTTCTTAAAGCCTGAAGTTTTGTCAACTTCAACTCCTGAAGAAGTTATTAGTGCACATTTTAGTGAGGATGCTTTGCTTGAGGA AGAGGATGCATCTGAACAGGACATTCACTTAGCTCTAGAGTCTGATAACTCAAGCAGTAAGTCAAGCTGTTCCTCATGGACAAGCCGGTCTGTTGCTTCAGGCTTTCAGTACCACCCTAATCTTCCCA TGCATGCTGTCATTATGGAAAAGTCCAATGATCATTTCATTGTGAAAATACGGCGTGCAACACCATCTACCTCCCCTGGCCTTAAACATGGTATGGTAGCTGAGGAGTCGTTGACACCTTTGCCTAGA ACTGGAAAAGAAGCTGATGGGGCAGCAGAGAAAGAACCTACCCTGTTTCAGAGTACAGTTTTAAACCCTGTCCAAGACTTGGAAAATTCCGACAAAAGTATTGATAAGAGCAAACCAACTCATGAAGA TCAGAACTCTATAGTACAAACACAGGTTCCAGATATATACGAATTTCTTAAAGATGCTTCAAATAAGGTGGTTCATTGTGATCAAGTGGTTGATGATTGCTTCAAGTTGCATCAAGTATGGGAACCAA AAGTTTCTGAGAGCCTTCAAGAATTGCCTTCAATGGAAAAAAATGCACACTCTGTTGATGATCATCTTCCTAATACACACATAGATCTAACAAAAGATCCAGCTACTGAGACTAAAAGCTTGGAGCTA ATGGATGTAACAGTTTTAGATATCGATCACTTGGAACATTCTAAACCCAACTTAGATCAAGATGCACAGATAACGTGTACTTCGTTACAGCATGATGCTGTAGATGCTTTTATTGATTTGACACATGA TGTTTCAAATGAGAGTAAAAACGAAAGTAATGAACCTGTGTTAACTGTTGAAGGTGTGGGATGCCAGGTAATATGTATAGATGACGATAACCACAAAGAAGGAAAAGTGGGGAAGGTAAACAGTTCCT TAGAATGTACTGTTGAGGAAACCTGTATTGACTTGACCTCAGAGTCTGCTGGCTCCTTTGAAGTAAAGAGACACACTTTAAAGTCAGAGCCTCCATCAAAGTCGGATTGTTTAGAGTTGCCTGAGACT CTGGGGAATGGTCACAAGAAGAGAAAGAACAGTCCTGCTGTGAGTCACTCTTCTCAGAAAAAGCAAAGAAAGGACATGGACTTAAGTAGTGAAAAGACCAAGAGACTTAGTCCTAATTCTGATAGAAC TGGTGATGCTCACAGAAAGCATGGCAGCAAGAAGAGGGAACCTGCAGTAAGTGACACATCCTTGTCATCAGAGGTCAACCCAGAGGTGAAGGGCTCAACAGCACCACTTGCTACTTTTCCAGGAAGCC TTTCTGCAAAAAATGTTATCAAAAAGAAAGGAGAAATTATAGTTTCATGGACAAGAAATGACGACAGGGAAATTTTACTGGAATGTCAGAAAAGAATGCCGTCCCTGAAAACATTTACCCACTTGGCT GTCAAACTGAATAAAAATCCAAATCAGGTTTCAGAGAGGTTCCAGCAACTGAAAAAGCTTTTTGAGAAGTCAAAATGCAGGTAGTAGTGGGTCCATCGCAGGATGCTAATGCTATGAGTTGCTGGATT TCATGGTGCCTCACTGATAATTCTTCTACAAAGAAGCTTCGATTCCTCGTGTTTTAAATGGGGAACTAGGTGGAGGTTTTGTCTCAGTTTTGGTGACTAGATGATCATCTACCTTTTTTTTACTTTCC TGGTCATTGTGCTTGGCTTATTCAGATCAACAGTCTGATTCACTTTCCTGTTATTGGTCAGAATATTTATTTTTAATCATTAAAAGTTGTTATCAAATGAAAGAATAAAAGCAACCTCAATGTAATAC TGAAACCTTAGTTTTGATATTGGATGAAATAACTTCTTTAGATTTTAAAAAACAATTTTGTAGCATTTTAAATGTAATGACTATTTAGTTCACCTTTCTATTCATTTTTGTTTTTATAATTGCCTCAT TTTGGAAAATTGTGAAATAATTTAAATAGTATATTTGTATATATGTATAATTATTGTAATGTAAAATACTATGACTGTATGTGTCTTGAGTGTATGTATGCACATGAATGGCTTTGCTAGCCAAAGGG TTTTTTTATCTATATAAAATATTTTGTATAAACTTTCCTTTCAGTTAGTCATGTATAATAAAAACATGTAAAGTCCTTTTTATTTTTA
hide sequence
RefSeq Acc Id:
NP_001101391 ⟸ NM_001107921
- UniProtKB:
D4A7V6 (UniProtKB/TrEMBL), A6IIJ5 (UniProtKB/TrEMBL)
- Sequence:
MAADDDNGDGTGLFDVCPASPLKNNDEGSLDIYAGLDSTVSDSTARSCVSFRNCLDLYEEILTEEGTAKEATYSDLQIEYGKCQQQMKDLMKRFKEIQTQNLNLKNENQSLKKNISALIKTARVEINR KDEEINHLHQRLSEFPHFRNNHKTARTKDSRSKSPHLDNCSKTDHGVKSDVQKDIHPNTSQPNLEKEGKSHSEAQNSLHLSTGIEKHCTNNVWSRSPYQVSEGNSNEDNRRGRNGVRHSQGSRGTDRT QKDLNSSCNDGEPRDKEAASRLHGNPEKHGSSEARAENKISEIKSSTGLGNKSERSASSWEKETSRERPHTRVEPQNDKNLERQNERLQNTHRKELQSQDKAERKGDVKFKPAGEEQGHRGRVDRALP PHSKNDMKYYGFNKYHPEERRGREDGKRDRGMSSHGFQDRRCSSSLSSNRNSKYPHSKEVSVAHQWENTPFKAERHRTEDRRKRERENKEESRHVKSDKKSPPEHLQRTHKDTKKSTANGKRQTEQKH GKGPVSTSELSKGTDNRECTMKVENGPNEAKGKDLKLSFMEKLNLTLSPAKKQPVCQDNEHQIIGVPKPSGVCDSQSLEKTETVACLPSVSEQDREEPKSELPEPKEALSATSQPRTSIPENKVKEEN RLLFKSVENTVPCELLACGTEISFPAPVEIEQARCLVQSMEVEETCAGARAAASVVMRVLPEHASEDFSQELGTKRHDDINSCDISEGGKKKVVLSPKAAAASESHLEPVVEEPSISPVNCSGDNNPK LEPSLEERPKVENKSSPLEPCLPKEMFVPSPQKTELIDHKIDTGESNSVYQDDDNSVLSIDFNNLRPIPEPISPLNSPVRPVSKVLSMESSCTIPLYDSSHKDEFPSNSTLSTFKSQSDLNKENEKPV PKLDKCSEAESCKNLSVDELEEGEIRSDDEESVAQKRLEKSARPRTSTEVPPGKISPGSRRSTVHVHKDNGRTVVKLPRDRITWSQRSNESRPSNTERKSKTMSISSLEKILPLILAPSSVWEVMHML RLLGKHVRKNYMKFKIKFSLTQFHRIIESAILSFTSLIRYLDLSKICKSVSTLQKSLCDVIESNLKQVKKNGIVDRLFEQQQTDMKKKLWKFVDEQLDYLFEKLKKILLKFCDSVKHENDSSEGKLGK KYKERAQHSNCQKKKMDNKEIRREKVLKSENTVNFKSSLGCEKFEEKHQDQNKTNTTTVKHDVKRTFSTCTDNNTKNSECKEQFLGMNCPSTPRPGETEGNVEEGTPAAQHACVKSERGFEILTEQQA SSLTFNLVSDAQMGEIFKSLLQGSDLLDTGGTEKAEWELKTPEKQLLESLKCESAPACTTEELVSEAASLCPKVISDDNWSLLSSEKGPSLSSGLSLPVHPDVLDENCMFEVSSNLALSKDNVYSSEK SKPCISSILLEDLAVSLTVPSPLKSDGHLSFLKPEVLSTSTPEEVISAHFSEDALLEEEDASEQDIHLALESDNSSSKSSCSSWTSRSVASGFQYHPNLPMHAVIMEKSNDHFIVKIRRATPSTSPGL KHGMVAEESLTPLPRTGKEADGAAEKEPTLFQSTVLNPVQDLENSDKSIDKSKPTHEDQNSIVQTQVPDIYEFLKDASNKVVHCDQVVDDCFKLHQVWEPKVSESLQELPSMEKNAHSVDDHLPNTHI DLTKDPATETKSLELMDVTVLDIDHLEHSKPNLDQDAQITCTSLQHDAVDAFIDLTHDVSNESKNESNEPVLTVEGVGCQVICIDDDNHKEGKVGKVNSSLECTVEETCIDLTSESAGSFEVKRHTLK SEPPSKSDCLELPETLGNGHKKRKNSPAVSHSSQKKQRKDMDLSSEKTKRLSPNSDRTGDAHRKHGSKKREPAVSDTSLSSEVNPEVKGSTAPLATFPGSLSAKNVIKKKGEIIVSWTRNDDREILLE CQKRMPSLKTFTHLAVKLNKNPNQVSERFQQLKKLFEKSKCR
hide sequence
RefSeq Acc Id:
XP_006238035 ⟸ XM_006237973
- Peptide Label:
isoform X1
- UniProtKB:
D4A7V6 (UniProtKB/TrEMBL), A6IIJ5 (UniProtKB/TrEMBL)
- Sequence:
MAADDDNGDGTGLFDVCPASPLKNNDEGSLDIYAGLDSTVSDSTARSCVSFRNCLDLYEEILTE EGTAKEATYSDLQIEYGKCQQQMKDLMKRFKEIQTQNLNLKNENQSLKKNISALIKTARVEINRKDEEINHLHQRLSEFPHFRNNHKTARTKDSRSKSPHLDNCSKTDHGVKSDVQKDIHPNTSQPNL EKEGKSHSEAQNSLHLSTGIEKHCTNNVWSRSPYQVSEGNSNEDNRRGRNGVRHSQGSRGTDRTQKDLNSSCNDGEPRDKEAASRLHGNPEKHGSSEARAENKISEIKSSTGLGNKSERSASSWEKET SRERPHTRVEPQNDKNLERQNERLQNTHRKELQSQDKAERKGDVKFKPAGEEQGHRGRVDRALPPHSKNDMKYYGFNKYHPEERRGREDGKRDRGMSSHGFQDRRCSSSLSSNRNSKYPHSKEVSVAH QWENTPFKAERHRTEDRRKRERENKEESRHVKSDKKSPPEHLQRTHKDTKKSTANGKRQTEQKHGKGPVSTSELSKGTDNRECTMKVENGPNEAKGKDLKLSFMEKLNLTLSPAKKQPVCQDNEHQII GVPKPSGVCDSQSLEKTETVACLPSVSEQDREEPKSELPEPKEALSATSQPRTSIPENKVKEENRLLFKSVENTVPCELLACGTEISFPAPVEIEQARCLVQSMEVEETCAGARAAASVVMRVLPEHA SEDFSQELGTKRHDDINSCDISEGGKKKVVLSPKAAAASESHLEPVVEEPSISPVNCSGDNNPKLEPSLEERPKVENKSSPLEPCLPKEMFVPSPQKTELIDHKIDTGESNSVYQDDDNSVLSIDFNN LRPIPEPISPLNSPVRPVSKVLSMESSCTIPLYDSSHKDEFPSNSTLSTFKSQSDLNKENEKPVPKLDKCSEAESCKNLSVDELEEGEIRSDDEESVAQKRLEKSARPRTSTEVPPGKISPGSRRSTV HVHKDNGRTVVKLPRDRITWSQRSNESRPSNTERKSKTMSISSLEKILPLILAPSSVWEVMHMLRLLGKHVRKNYMKFKIKFSLTQFHRIIESAILSFTSLIRYLDLSKICKSVSTLQKSLCDVIESN LKQVKKNGIVDRLFEQQQTDMKKKLWKFVDEQLDYLFEKLKKILLKFCDSVKHENDSSEGKLGKKYKERAQHSNCQKKKMDNKEIRREKVLKSENTVNFKSSLGCEKFEEKHQDQNKTNTTTVKHDVK RTFSTCTDNNTKNSECKEQFLGMNCPSTPRPGETEGNVEEGTPAAQHACVKSERGFEILTEQQASSLTFNLVSDAQMGEIFKSLLQGSDLLDTGGTEKAEWELKTPEKQLLESLKCESAPACTTEELV SEAASLCPKVISDDNWSLLSSEKGPSLSSGLSLPVHPDVLDENCMFEVSSNLALSKDNVYSSEKSKPCISSILLEDLAVSLTVPSPLKSDGHLSFLKPEVLSTSTPEEVISAHFSEDALLEEEDASEQ DIHLALESDNSSSKSSCSSWTSRSVASGFQYHPNLPMHAVIMEKSNDHFIVKIRRATPSTSPGLKHGMVAEESLTPLPRTGKEADGAAEKEPTLFQSTVLNPVQDLENSDKSIDKSKPTHEDQNSIVQ TQVPDIYEFLKDASNKVVHCDQVVDDCFKLHQVWEPKVSESLQELPSMEKNAHSVDDHLPNTHIDLTKDPATETKSLELMDVTVLDIDHLEHSKPNLDQDAQITCTSLQHDAVDAFIDLTHDVSNESK NESNEPVLTVEGVGCQVICIDDDNHKEGKVGKVNSSLECTVEETCIDLTSESAGSFEVKRHTLKSEPPSKSDCLELPETLGNGHKKRKNSPAVSHSSQKKQRKDMDLSSEKTKRLSPNSDRTGDAHRK HGSKKREPAVSDTSLSSEVNPEVKGSTAPLATFPGSLSAKNVIKKKGEIIVSWTRNDDREILLECQKRMPSLKTFTHLAVKLNKNPNQVSERFQQLKKLFEKSKCR
hide sequence
RefSeq Acc Id:
XP_006238037 ⟸ XM_006237975
- Peptide Label:
isoform X1
- UniProtKB:
D4A7V6 (UniProtKB/TrEMBL), A6IIJ5 (UniProtKB/TrEMBL)
- Sequence:
MAADDDNGDGTGLFDVCPASPLKNNDEGSLDIYAGLDSTVSDSTARSCVSFRNCLDLYEEILTEEGTAKEATYSDLQIEYGKCQQQMKDLMKRFKEIQTQNLNLKNENQSLKKNISALIKTARVEINR KDEEINHLHQRLSEFPHFRNNHKTARTKDSRSKSPHLDNCSKTDHGVKSDVQKDIHPNTSQPNLEKEGKSHSEAQNSLHLSTGIEKHCTNNVWSRSPYQVSEGNSNEDNRRGRNGVRHSQGSRGTDRT QKDLNSSCNDGEPRDKEAASRLHGNPEKHGSSEARAENKISEIKSSTGLGNKSERSASSWEKETSRERPHTRVEPQNDKNLERQNERLQNTHRKELQSQDKAERKGDVKFKPAGEEQGHRGRVDRALP PHSKNDMKYYGFNKYHPEERRGREDGKRDRGMSSHGFQDRRCSSSLSSNRNSKYPHSKEVSVAHQWENTPFKAERHRTEDRRKRERENKEESRHVKSDKKSPPEHLQRTHKDTKKSTANGKRQTEQKH GKGPVSTSELSKGTDNRECTMKVENGPNEAKGKDLKLSFMEKLNLTLSPAKKQPVCQDNEHQIIGVPKPSGVCDSQSLEKTETVACLPSVSEQDREEPKSELPEPKEALSATSQPRTSIPENKVKEEN RLLFKSVENTVPCELLACGTEISFPAPVEIEQARCLVQSMEVEETCAGARAAASVVMRVLPEHASEDFSQELGTKRHDDINSCDISEGGKKKVVLSPKAAAASESHLEPVVEEPSISPVNCSGDNNPK LEPSLEERPKVENKSSPLEPCLPKEMFVPSPQKTELIDHKIDTGESNSVYQDDDNSVLSIDFNNLRPIPEPISPLNSPVRPVSKVLSMESSCTIPLYDSSHKDEFPSNSTLSTFKSQSDLNKENEKPV PKLDKCSEAESCKNLSVDELEEGEIRSDDEESVAQKRLEKSARPRTSTEVPPGKISPGSRRSTVHVHKDNGRTVVKLPRDRITWSQRSNESRPSNTERKSKTMSISSLEKILPLILAPSSVWEVMHML RLLGKHVRKNYMKFKIKFSLTQFHRIIESAILSFTSLIRYLDLSKICKSVSTLQKSLCDVIESNLKQVKKNGIVDRLFEQQQTDMKKKLWKFVDEQLDYLFEKLKKILLKFCDSVKHENDSSEGKLGK KYKERAQHSNCQKKKMDNKEIRREKVLKSENTVNFKSSLGCEKFEEKHQDQNKTNTTTVKHDVKRTFSTCTDNNTKNSECKEQFLGMNCPSTPRPGETEGNVEEGTPAAQHACVKSERGFEILTEQQA SSLTFNLVSDAQMGEIFKSLLQGSDLLDTGGTEKAEWELKTPEKQLLESLKCESAPACTTEELVSEAASLCPKVISDDNWSLLSSEKGPSLSSGLSLPVHPDVLDENCMFEVSSNLALSKDNVYSSEK SKPCISSILLEDLAVSLTVPSPLKSDGHLSFLKPEVLSTSTPEEVISAHFSEDALLEEEDASEQDIHLALESDNSSSKSSCSSWTSRSVASGFQYHPNLPMHAVIMEKSNDHFIVKIRRATPSTSPGL KHGMVAEESLTPLPRTGKEADGAAEKEPTLFQSTVLNPVQDLENSDKSIDKSKPTHEDQNSIVQTQVPDIYEFLKDASNKVVHCDQVVDDCFKLHQVWEPKVSESLQELPSMEKNAHSVDDHLPNTHI DLTKDPATETKSLELMDVTVLDIDHLEHSKPNLDQDAQITCTSLQHDAVDAFIDLTHDVSNESKNESNEPVLTVEGVGCQVICIDDDNHKEGKVGKVNSSLECTVEETCIDLTSESAGSFEVKRHTLK SEPPSKSDCLELPETLGNGHKKRKNSPAVSHSSQKKQRKDMDLSSEKTKRLSPNSDRTGDAHRKHGSKKREPAVSDTSLSSEVNPEVKGSTAPLATFPGSLSAKNVIKKKGEIIVSWTRNDDREILLE CQKRMPSLKTFTHLAVKLNKNPNQVSERFQQLKKLFEKSKCR
hide sequence
RefSeq Acc Id:
XP_006238036 ⟸ XM_006237974
- Peptide Label:
isoform X1
- UniProtKB:
D4A7V6 (UniProtKB/TrEMBL), A6IIJ5 (UniProtKB/TrEMBL)
- Sequence:
MAADDDNGDGTGLFDVCPASPLKNNDEGSLDIYAGLDSTVSDSTARSCVSFRNCLDLYEEILTE EGTAKEATYSDLQIEYGKCQQQMKDLMKRFKEIQTQNLNLKNENQSLKKNISALIKTARVEINRKDEEINHLHQRLSEFPHFRNNHKTARTKDSRSKSPHLDNCSKTDHGVKSDVQKDIHPNTSQPNL EKEGKSHSEAQNSLHLSTGIEKHCTNNVWSRSPYQVSEGNSNEDNRRGRNGVRHSQGSRGTDRTQKDLNSSCNDGEPRDKEAASRLHGNPEKHGSSEARAENKISEIKSSTGLGNKSERSASSWEKET SRERPHTRVEPQNDKNLERQNERLQNTHRKELQSQDKAERKGDVKFKPAGEEQGHRGRVDRALPPHSKNDMKYYGFNKYHPEERRGREDGKRDRGMSSHGFQDRRCSSSLSSNRNSKYPHSKEVSVAH QWENTPFKAERHRTEDRRKRERENKEESRHVKSDKKSPPEHLQRTHKDTKKSTANGKRQTEQKHGKGPVSTSELSKGTDNRECTMKVENGPNEAKGKDLKLSFMEKLNLTLSPAKKQPVCQDNEHQII GVPKPSGVCDSQSLEKTETVACLPSVSEQDREEPKSELPEPKEALSATSQPRTSIPENKVKEENRLLFKSVENTVPCELLACGTEISFPAPVEIEQARCLVQSMEVEETCAGARAAASVVMRVLPEHA SEDFSQELGTKRHDDINSCDISEGGKKKVVLSPKAAAASESHLEPVVEEPSISPVNCSGDNNPKLEPSLEERPKVENKSSPLEPCLPKEMFVPSPQKTELIDHKIDTGESNSVYQDDDNSVLSIDFNN LRPIPEPISPLNSPVRPVSKVLSMESSCTIPLYDSSHKDEFPSNSTLSTFKSQSDLNKENEKPVPKLDKCSEAESCKNLSVDELEEGEIRSDDEESVAQKRLEKSARPRTSTEVPPGKISPGSRRSTV HVHKDNGRTVVKLPRDRITWSQRSNESRPSNTERKSKTMSISSLEKILPLILAPSSVWEVMHMLRLLGKHVRKNYMKFKIKFSLTQFHRIIESAILSFTSLIRYLDLSKICKSVSTLQKSLCDVIESN LKQVKKNGIVDRLFEQQQTDMKKKLWKFVDEQLDYLFEKLKKILLKFCDSVKHENDSSEGKLGKKYKERAQHSNCQKKKMDNKEIRREKVLKSENTVNFKSSLGCEKFEEKHQDQNKTNTTTVKHDVK RTFSTCTDNNTKNSECKEQFLGMNCPSTPRPGETEGNVEEGTPAAQHACVKSERGFEILTEQQASSLTFNLVSDAQMGEIFKSLLQGSDLLDTGGTEKAEWELKTPEKQLLESLKCESAPACTTEELV SEAASLCPKVISDDNWSLLSSEKGPSLSSGLSLPVHPDVLDENCMFEVSSNLALSKDNVYSSEKSKPCISSILLEDLAVSLTVPSPLKSDGHLSFLKPEVLSTSTPEEVISAHFSEDALLEEEDASEQ DIHLALESDNSSSKSSCSSWTSRSVASGFQYHPNLPMHAVIMEKSNDHFIVKIRRATPSTSPGLKHGMVAEESLTPLPRTGKEADGAAEKEPTLFQSTVLNPVQDLENSDKSIDKSKPTHEDQNSIVQ TQVPDIYEFLKDASNKVVHCDQVVDDCFKLHQVWEPKVSESLQELPSMEKNAHSVDDHLPNTHIDLTKDPATETKSLELMDVTVLDIDHLEHSKPNLDQDAQITCTSLQHDAVDAFIDLTHDVSNESK NESNEPVLTVEGVGCQVICIDDDNHKEGKVGKVNSSLECTVEETCIDLTSESAGSFEVKRHTLKSEPPSKSDCLELPETLGNGHKKRKNSPAVSHSSQKKQRKDMDLSSEKTKRLSPNSDRTGDAHRK HGSKKREPAVSDTSLSSEVNPEVKGSTAPLATFPGSLSAKNVIKKKGEIIVSWTRNDDREILLECQKRMPSLKTFTHLAVKLNKNPNQVSERFQQLKKLFEKSKCR
hide sequence
Ensembl Acc Id:
ENSRNOP00000075576 ⟸ ENSRNOT00000079656
Ensembl Acc Id:
ENSRNOP00000009227 ⟸ ENSRNOT00000009228
Ensembl Acc Id:
ENSRNOP00000085206 ⟸ ENSRNOT00000101963
RGD ID: 13693608
Promoter ID: EPDNEW_R4133
Type: initiation region
Name: Casp8ap2_1
Description: caspase 8 associated protein 2
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 5 47,853,764 - 47,853,824 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Casp8ap2
caspase 8 associated protein 2
Casp8ap2_predicted
caspase 8 associated protein 2 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Casp8ap2_predicted
caspase 8 associated protein 2 (predicted)
Symbol and Name status set to approved
70820
APPROVED